Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulatory approval in one or more important markets; (iii) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of the application of Nektar's technology platforms to potential new drug candidates is therefore very uncertain and unpredictable and one or more research and development programs could fail; (iv) Nektar's patent applications for its proprietary or partner product candidates may not issue, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required in the future; (v) the outcome of any future intellectual property or other litigation related to Nektar's proprietary product candidates or complex commercial agreements; (vi) if Nektar is unable to establish and maintain collaboration partnerships on attractive commercial terms (such as for NKTR-102), our business, results of operations and financial condition could suffer; and (vii) certain other important risks and uncertainties set forth in Nektar's Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 filed with the SEC on July 28, 2010, the Current Report on Form 8-K filed with the SEC today, and the Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 to be filed with the SEC on or about November 4, 2010.  Actual results could differ materially from the forward-looking statements contained in this press release.  Nektar undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise.

Nektar Investor Inquiries:Jennifer Ruddock/Nektar Therapeutics(650) 631-4954Susan Noonan/SA Noonan Communications, LLC(212) 966-3650Nektar Media Inquiries: Karen Bergman/BCC Partners(650) 575-1509 Michelle Corral/BCC Partners(415) 794-866
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... NASHVILLE, Tenn. , Aug. 19, 2014 /PRNewswire/ ... to provide its patient experience technology to ... Health. Under the five-year agreement, CarePoint Health will ... of Bayonne Medical Center, Christ Hospital and Hoboken ... platform offers a range of software solutions to ...
(Date:8/19/2014)... BIRMINGHAM, Ala. , Aug. 19, 2014  The Alabama ... re-affirmed that patients can sue drug makers who mislead doctors ... cause harmful side‑effects.  The case is Weeks v. Wyeth, and ... drug makers in that same case last year. Heninger Garrison ... represent the patient in the case, Danny Weeks ...
(Date:8/19/2014)... , Aug. 19, 2014 Talyst, a ... be exhibiting at the 2014 NPPA Summer Conference in ... will be showcasing its 340B software products and services. ... 340B splitting solutions, supplying over 400 customers with a ... of 340B solutions including its latest solution, AutoSplit® Contract ...
Breaking Medicine Technology:Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Talyst Exhibits at the NPPA Summer Conference 2
... 24 NacTel (North Atlantic Communications), a leading ... successfully installed and integrated a new state-of-the-art customer ... one of the fastest growing durable medical equipment ... sophisticated feature set to serve its customers, and ...
... Inc. and Cedarlane today announced that they have entered ... distribute high value reagent proteins produced by Pfenex to ... products initially distributed will be vaccine carrier proteins such ... related growth factors including G-CSF and Interferon beta 1-b. ...
Cached Medicine Technology:Drive Medical Equipment Chooses NacTel with ShoreTel as its Critical Communications Provider 2Drive Medical Equipment Chooses NacTel with ShoreTel as its Critical Communications Provider 3Drive Medical Equipment Chooses NacTel with ShoreTel as its Critical Communications Provider 4Pfenex Inc. Establishes Reagent Protein Distribution Agreement With Cedarlane Corporation 2
(Date:8/20/2014)... Ticketability.com has Theresa Caputo tickets for ... well-known medium has been thrilling many with her amazing ... cities, with tickets becoming available August 15. , Among ... Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, Charlotte, Houston, New ... Diego. The medium’s fans can obtain Theresa Caputo tour ...
(Date:8/20/2014)... 20, 2014 BuyCheapTicketsToEvents.com is always ... selection of tickets to many events. Cheap NHL hockey tickets ... in September. , Hockey fans are enthusiastic about their sport, ... for games. Now is the time to acquire 2014 NHL ... mere months. There will be a great deal of action ...
(Date:8/20/2014)... 2014 Blaine Labs®, the creators ... RevitaDERM® Psoriasis Treatment to ease the redness, ... This all-in-one product was created to treat, moisturize, ... is powered by coal tar and formulated to ... effective ingredient. , RevitaDERM® Psoriasis Treatment is ...
(Date:8/20/2014)... August 20, 2014 Low market concentration, ... availability of substitutes typify the market for packaging design ... 3.1 out of 5, indicating a moderate level of ... and suppliers have an equal amount of leverage during ... , First, few substitutes exist for packaging design ...
(Date:8/20/2014)... 2014 The “Human Insulin Market ... Acting, Premixed), Modern Human Insulin (Rapid Acting, Long ... Novomix, Tresiba, Others) - Forecast to 2019” provides ... opportunities, current market trends,and strategies impacting the global ... forecasts of the revenue and share analysis. , ...
Breaking Medicine News(10 mins):Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:2014 NHL Preseason Tickets Are Among Top Selling Seats at Trusted Provider BuyCheapTicketsToEvents.com 2Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 4Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4
... , IRVINE, Calif., Nov. 30 A revolutionary new ... seamless, real-time access to diagnostic images and reports with ... by Candelis, Inc., one of the fastest growing providers ... By improving workflow and doing away with the cumbersome ...
... blood-borne diseases, researchers say , MONDAY, Nov. 30 (HealthDay ... putting them at risk for blood-borne diseases, but they ... risk of infection, a new study has found. , ... centers and found that 415 -- 59 percent -- ...
... , LOS ANGELES, Nov. 30 Menopause - it,s an ... a host of uncomfortable symptoms that negatively impact quality of life. ... sweats and lethargy are just some of the life-altering symptoms of ... can show up a full ten years before actual menopause occurs ...
... ... new poll released today by Latino Decisions, the Robert Wood Johnson Foundation ... and impreMedia, shows a widespread consensus among the Latino/Hispanic electoral about the ... coverage. For the first time, health care tops the list of national ...
... , NEW YORK, Nov. 30 Of the more than ... nearly half are African American. Moreover, the HIV/AIDS infection rates in Washington, ... and Black women account for more than 90 percent of all women ... at 6:00 p.m.*, World AIDS Day, BET shines a light on these ...
... and extensive discussion in the scientific community, the Institute ... its methods for evaluating the relation between cost and ... working on certain commissions awarded by the Federal Joint ... for passing on recommendations to the GKV-Spitzenverband [National Association ...
Cached Medicine News:Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 2Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 3Health News:Med Students Often Fail to Report Needlestick Injuries 2Health News:Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 4Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 5Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 6Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 7Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 8Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 9Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5
Stainless steel. Lamp is in fiberoptic handle. Green color coding. The blade includes a port that permits delivery of oxygen or other gas mixtures during intubation....
... of the vocal cords in even the most ... like a standard laryngoscope, Viewmax® does not require ... its ability to allow intubation whether you are ... airway. It has a patented lens system that ...
... Stainless steel. Lamp supplied with ... operate on any standard/conventional handle allowing ... illumination without the potential confusion from ... blades offer an easy and cost ...
... The FR-120F, Fujinon's new fiberoptic Naso-Pharyngo-Laryngoscope provides ... patient comfort. The latest in Fujinon ... increased light guide, and a wide 90 ... impressive 3.3mm distal tip diameter. In ...
Medicine Products: